China Medical Technologies, a medical device company, has received approval from the State Food and Drug Administration or SFDA in the People's Republic of China for its Bladder Cancer FISH Probe.
Subscribe to our email newsletter
The probe is an advanced molecular diagnostic test kit that uses DNA probes for early detection and monitoring the course of bladder cancer.
It is designed to detect and identify whether aneuploidy for chromosomes three, seven, 17 and loss of the p16 locus are present in the human bladder cells, the company said.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.